Gut microbiota profiling in injection drug users with and without HIV-1 infection in Puerto Rico
2024

Gut Microbiota in Injection Drug Users with and without HIV-1 in Puerto Rico

Sample size: 168 publication 10 minutes Evidence: moderate

Author Information

Author(s): Aluthge Nirosh, Adams Seidu, Davila Carmen A., Gocchi Carrasco Nova R., Chiou Kathy S., Abadie Roberto, Bennett Sydney J., Dombrowski Kirk, Major Angel M., Valentín-Acevedo Aníbal, West John T., Wood Charles, Fernando Samodha C.

Primary Institution: University of Nebraska-Lincoln

Hypothesis

How do HIV status and injection drug use affect gut microbiota composition?

Conclusion

The study found significant differences in gut microbiota composition based on HIV status and drug use, with multiple drug use notably affecting microbial community structure.

Supporting Evidence

  • The HIV-positive group had a higher abundance of certain bacteria like Prevotella.
  • Multiple drug use significantly affected the gut microbiome composition.
  • Different bacterial taxa were enriched in drug injectors compared to non-injectors.

Takeaway

This study looked at how HIV and drug use change the bacteria in people's guts, finding that both factors can change the types of bacteria present.

Methodology

The study used 16S rDNA sequencing to analyze gut microbiota in a cohort of injection drug users in Puerto Rico.

Potential Biases

Potential biases may arise from the self-reported HIV status and drug use.

Limitations

The study faced challenges in participant recruitment, leading to unequal group sizes.

Participant Demographics

Participants included drug injectors and non-injectors, both HIV-positive and HIV-negative, from Puerto Rico.

Statistical Information

P-Value

p=0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fmicb.2024.1470037

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication